211 related articles for article (PubMed ID: 22761740)
81. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.
Taha TA; Osta W; Kozhaya L; Bielawski J; Johnson KR; Gillanders WE; Dbaibo GS; Hannun YA; Obeid LM
J Biol Chem; 2004 May; 279(19):20546-54. PubMed ID: 14988393
[TBL] [Abstract][Full Text] [Related]
82. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.
Youm JK; Jo H; Hong JH; Shin DM; Kwon MJ; Jeong SK; Park BD; Choi EH; Lee SH
J Dermatol Sci; 2008 Aug; 51(2):89-102. PubMed ID: 18420384
[TBL] [Abstract][Full Text] [Related]
83. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
[TBL] [Abstract][Full Text] [Related]
84. Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes.
Rao TS; Lariosa-Willingham KD; Lin FF; Palfreyman EL; Yu N; Chun J; Webb M
Brain Res; 2003 Nov; 990(1-2):182-94. PubMed ID: 14568343
[TBL] [Abstract][Full Text] [Related]
85. Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.
Schwalm S; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2010 Aug; 160(7):1641-51. PubMed ID: 20649568
[TBL] [Abstract][Full Text] [Related]
86. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
87. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5.
Usui S; Sugimoto N; Takuwa N; Sakagami S; Takata S; Kaneko S; Takuwa Y
J Biol Chem; 2004 Mar; 279(13):12300-11. PubMed ID: 14711826
[TBL] [Abstract][Full Text] [Related]
88. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
89. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis.
Lai WQ; Irwan AW; Goh HH; Howe HS; Yu DT; Valle-Oñate R; McInnes IB; Melendez AJ; Leung BP
J Immunol; 2008 Dec; 181(11):8010-7. PubMed ID: 19017993
[TBL] [Abstract][Full Text] [Related]
90. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal.
Gude DR; Alvarez SE; Paugh SW; Mitra P; Yu J; Griffiths R; Barbour SE; Milstien S; Spiegel S
FASEB J; 2008 Aug; 22(8):2629-38. PubMed ID: 18362204
[TBL] [Abstract][Full Text] [Related]
91. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Beljanski V; Lewis CS; Smith CD
Cancer Biol Ther; 2011 Mar; 11(5):524-34. PubMed ID: 21258214
[TBL] [Abstract][Full Text] [Related]
92. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines.
McCracken MA; Miraglia LJ; McKay RA; Strobl JS
Mol Cancer Ther; 2003 Mar; 2(3):273-81. PubMed ID: 12657722
[TBL] [Abstract][Full Text] [Related]
93. Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells.
Liu X; Hong Q; Wang Z; Yu Y; Zou X; Xu L
Exp Biol Med (Maywood); 2016 Feb; 241(3):265-72. PubMed ID: 26376826
[TBL] [Abstract][Full Text] [Related]
94. Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function.
Ghazaly EA; Miraki-Moud F; Smith P; Gnanaranjan C; Koniali L; Oke A; Saied MH; Petty R; Matthews J; Stronge R; Joel SP; Young BD; Gribben J; Taussig DC
J Biol Chem; 2020 Apr; 295(16):5496-5508. PubMed ID: 32161116
[TBL] [Abstract][Full Text] [Related]
95. The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death.
Pastukhov O; Schwalm S; Zangemeister-Wittke U; Fabbro D; Bornancin F; Japtok L; Kleuser B; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2014 Dec; 171(24):5829-44. PubMed ID: 25134723
[TBL] [Abstract][Full Text] [Related]
96. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
97. Recent advances in the development of sphingosine kinase inhibitors.
Pitman MR; Costabile M; Pitson SM
Cell Signal; 2016 Sep; 28(9):1349-1363. PubMed ID: 27297359
[TBL] [Abstract][Full Text] [Related]
98. Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.
Kajimoto T; Caliman AD; Tobias IS; Okada T; Pilo CA; Van AN; Andrew McCammon J; Nakamura SI; Newton AC
Sci Signal; 2019 Jan; 12(562):. PubMed ID: 30600259
[TBL] [Abstract][Full Text] [Related]
99. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
[TBL] [Abstract][Full Text] [Related]
100. Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival.
Lim KG; Gray AI; Pyne S; Pyne NJ
Br J Pharmacol; 2012 Jul; 166(5):1605-16. PubMed ID: 22251058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
